A comprehensive view of Regeneron Pharmaceuticals Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Australia: Regeneron Pharmaceuticals, Sanofi Biotechnology Receive Patent for 'Compositions for the treatment of rheumatoid arthritis and methods of using same'
Published:
April 19, 2024
by Australian Government
|
Australia: Regeneron Pharmaceuticals Receives Patent for 'Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist'
Published:
April 19, 2024
by Australian Government
|
Australia: Regeneron Pharmaceuticals Receives Patent for 'Devices and methods for precision dose delivery'
Published:
April 19, 2024
by Australian Government
|
Regeneron Pharma Granted United States Patent for High Confidence Compound Identification by Liquid Chromatography-Mass Spectrometry
Published:
April 18, 2024
by Pharmaceutical Patent News
|
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER WITH BISPECIFIC EGFR X CD28 ANTIBODIES ALONE OR IN COMBINATION WITH ANTI-PD-1 ANTIBODIES"
Published:
April 17, 2024
by U.S. Fed News
|
Ask us about our Tissue & Hygiene market view